Table 3.
Growth of FLR under two surgical methods
| Index | TACE + PVE group (n = 11) |
PALPP group (n = 16) |
P value |
|---|---|---|---|
| SLV (ml) (median [IQR]) | 1147.9 (1068.6, 1251.5) | 1192.8 (1133.4, 1241.7) | 0.278 |
| Liver volume growth time (day) (median [IQR]) | 66 (41.0, 118.0) | 18.5 (12.5, 37.0) | 0.001 |
| FLR1 (ml) (median [IQR]) | 383.3 (339.5, 447.0) | 368.1 (308.3, 400.8) | 0.43 |
| FLR2 (ml) (median [IQR]) | 502.2 (400.0, 586.8) | 526.0 (456.6, 569.6) | 0.657 |
| FLR3 (ml) (median [IQR]) | 83.1 (43.9, 182.8) | 158.4 (95.5, 206.4) | 0.043 |
| FLR † (%) (median [IQR]) | 23 (12.0,47.0) | 43 (29, 58.5) | 0.026 |
| KGR (ml/w) (median [IQR]) | 7.7 (3.2, 33.7) | 58.5 (25.2 108.6) | 0.001 |
SLV standard liver volume; Liver volume growth time, The waiting time between procedures or the time span from phase I surgery to treatment failure, FLR1 First pre-operative FLR, FLR2 FLR before second surgery or FLR at the time of treatment failure, FLR3 FLR3 = FLR2-FLR1; FLR †, The increase in FLR between the two procedures was divided by the FLR before the first procedure (FLR † = FLR3/ FLR1); KGR, Degree of liver volume increase (%)/time elapsed from baseline to final volume before stage II hepatectomy (weeks)